Perspective Therapeutics News and Activities

Presence

Perspective Therapeutics develops radiopharmaceutical therapies and imaging products for cancer care. Its main offerings include targeted drug candidates, medical isotopes, and imaging support for hospitals, clinics, and oncology patients.

Perspective Therapeutics products and services overview:

Radiopharmaceutical therapies
Cancer imaging
Medical isotopes
Drug development

Revenue: ~$1 million

Employees: 120

Headquarters: Seattle, United States (USA)

Perspective Therapeutics is one of the...

Perspective Therapeutics is a company listed under the stock ticker CATX (US).

Executives

View the org chart displaying its 21 main executives

Most searched biographies at Perspective Therapeutics

Popular executive movements at Perspective Therapeutics

Joel Sendek has joined the company as Chief Financial Officer (posted on September 5 2025).
Juan Graham, Chief Financial Officer, has left the company (posted on September 5 2025).

Create your alert
to follow the executive moves at Perspective Therapeutics.